Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pan Tumor”

157 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 157 results

Testing effectiveness (Phase 2)Study completedNCT03668119
What this trial is testing

Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Who this might be right for
Pan Tumor
Bristol-Myers Squibb 212
Early research (Phase 1)UnknownNCT05488821
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.

Who this might be right for
Advanced Solid Tumors Harboring MAPK Pathway Alterations
Qilu Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01728233
What this trial is testing

Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis

Who this might be right for
Penile NeoplasmsCarcinoma, Squamous Cell
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 32
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)Looking for participantsNCT06096974
What this trial is testing

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Who this might be right for
Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd. 60
Not applicableStudy completedNCT04698499
What this trial is testing

Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study

Who this might be right for
DysphagiaHead and Neck Cancer
University of Alberta 18
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Not applicableUnknownNCT05308784
What this trial is testing

A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

Who this might be right for
Pan-cancer
Avera McKennan Hospital & University Health Center 730
Testing effectiveness (Phase 2)Study completedNCT01752920
What this trial is testing

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Who this might be right for
Solid Tumor
Basilea Pharmaceutica 119
Not applicableLooking for participantsNCT06276088
What this trial is testing

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Who this might be right for
ImmunotherapyHyperprogressionBiomarker
Nanfang Hospital, Southern Medical University 374
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)UnknownNCT03991559
What this trial is testing

A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT01121575
What this trial is testing

Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Pfizer 70
Not applicableLooking for participantsNCT06008392
What this trial is testing

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

Who this might be right for
CancerCancer Gene MutationPAN Gene Mutation+2 more
Mayo Clinic 500
Not applicableLooking for participantsNCT06517979
What this trial is testing

Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis

Who this might be right for
CancerLymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 10,000
Not applicableApproved For MarketingNCT05760586
What this trial is testing

Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma

Who this might be right for
Low-grade Glioma
Day One Biopharmaceuticals, Inc.
Not applicableLooking for participantsNCT06614179
What this trial is testing

A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established

Who this might be right for
Abdominal Neoplasm
Xiangdong Cheng 100,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07336953
What this trial is testing

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
West China Hospital 198
Not applicableLooking for participantsNCT07404202
What this trial is testing

A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Who this might be right for
Pan-tumor(NSCLC, GYN Cancers, BTC and UC)
AstraZeneca 2,100
Testing effectiveness (Phase 2)Looking for participantsNCT07640295
What this trial is testing

Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd. 80
Next Page